Cargando…
CD133作为肺癌干细胞标记物的应用及其局限性
Lung cancer is one of the most common tumor, which lacks of effective clinical treatment to lead to desirable prognosis. According to cancer stem cell hypothesis, lung cancer stem cells are considered to be responsible for carcinogenesis, development, metastasis, recurrence, invasion, resistance to...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999939/ https://www.ncbi.nlm.nih.gov/pubmed/22008114 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.10.10 |
Ejemplares similares
-
血清/血浆microRNAs作为肺癌诊断标记物的研究进展
Publicado: (2012) -
肺癌干细胞作为靶点的肺癌治疗策略研究进展
Publicado: (2018) -
非小细胞肺癌个体化治疗相关分子标记物
Publicado: (2011) -
肺癌骨转移诊断标记物研究进展
Publicado: (2018) -
肺干细胞和肺癌干细胞的研究进展
Publicado: (2015)